In July 2025, REPL announced it had received a CRL for its biologics license application (BLA) for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma patients who were PD-1 ...
Cedric is a college student who built an app called PepAI and hit $50,000 in revenue seven weeks after launch. So he built it in ~2 weeks using Repl.it + Claude as his "senior developer," Firebase for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results